BeStock  
Markets › Compare › TEVA vs GSK

TEVA vs GSK

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TEVA · Teva Pharmaceutical Industries$39.23 ▲ 1.79%
GSK · GlaxoSmithKline$47.76 ▼ 0.13%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

95118140162184Nov 24, '25May 26, '26Nov 20, '26
  • TEVA +58.4%
  • GSK +4.3%

Head to head

MetricTEVAGSK
Price$39.23$47.76
Change today▲ 1.79%▼ 0.13%
Market cap$45.77B$95.73B
Return, 3 months+6.2%-7.8%
Return, year to date+25.7%-0.1%
Return, 1 year+62.0%+3.9%
P/E (TTM)91.217.1
P/B5.73.9
P/E percentile vs own 5y99th77th
Dividend yield–3.75%
Revenue growth (YoY, latest qtr)-1.9%+4.0%
Net profit growth (YoY)-46.1%-20.6%
Gross margin53.5%72.6%
Operating margin19.2%19.1%
Net margin2.9%13.0%
Return on equity6.6%24.9%
Analyst target vs. price+31.4%+17.0%
Analyst buy share100%0%
RSI (14)4039
30-day volatility38.6%29.9%
Max drawdown, 1 year-21.8%-22.4%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyHold

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • GSK is the largest of the group by market value.
  • TEVA has returned the most over the past year.
  • GSK carries the lowest trailing P/E.
  • GSK is growing revenue fastest.
  • GSK keeps the most profit per dollar of sales.
  • GSK has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top